Company Overview
Snapshot
Founded in January 2024 by Dan Davidi, OHR Synbiosis operates with 11–50 employees. The company is currently in the Pre-Funding stage, focusing on developing its core technology.
Business overview
OHR Synbiosis is a synthetic biology company focused on sustainable chemical manufacturing. The company leverages engineered enzymes to convert CO₂-derived feedstocks into precise carbon chains, offering an alternative to traditional petroleum-based refining. This technology supports the production of bio-based materials, including sulfur-free fuels, contributing to decarbonization and circular economy objectives. OHR Synbiosis's scalable and cost-effective approach has applications across various industries, primarily within the Industrial Technologies sector, with a focus on material innovations and alternative fuels.
Log in to access full profile ›Company Intelligence Q&A
- What is OHR Synbiosis's primary focus?
- OHR Synbiosis is a synthetic biology company developing a novel platform for sustainable chemical manufacturing, utilizing engineered enzymes to transform CO₂-derived feedstocks into bio-based materials.
- When was OHR Synbiosis founded?
- OHR Synbiosis was founded in January 2024 by Dan Davidi.
- What problem does OHR Synbiosis aim to solve?
- OHR Synbiosis aims to eliminate the need for traditional petroleum-based refining processes by providing a sustainable and cost-effective alternative for producing chemicals and materials from CO₂-derived feedstocks.
- What types of products can be created using OHR Synbiosis's technology?
- OHR Synbiosis's technology enables the production of bio-based materials, such as sulfur-free fuels, from CO₂-derived feedstocks.
- What is the current stage of OHR Synbiosis's product development?
- OHR Synbiosis's product is currently in the R&D stage, focusing on developing its core technology for sustainable chemical manufacturing.